Stephanie Mgebroff

Medicine · Health Sciences

13h-index2.3kcitations64works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(46), Immune cells in cancer(15), Neuroblastoma Research and Treatments(13), Macrophage Migration Inhibitory Factor(13), Immunotherapy and Immune Responses(4)

Publications64 total

Outcomes of PLAT-02 and PLAT-03: Evaluating CD19 CAR T-Cell Therapy and CD19-expressing T-APC Support in Pediatric B-ALL
Blood·2025· 6 citedOpen Access
233 Early experience on ENLIGHTen-01: a phase 1 study of FITC-E2 CAR-T cells with CAR adaptor molecule UB-TT170 for relapsed/refractory osteosarcoma
Regular and Young Investigator Award Abstracts·2024Open Access
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL
Blood Advances·2024· 8 citedOpen Access
Locoregional CAR T Cells for the Treatment of CNS Tumors in Children: Investigational Drug Service Pharmacy Activities.
PubMed·2024· 4 citedOpen Access
STRIvE-02 Arm C: Phase 1 study of concurrent PD-1 inhibition with B7-H3 CAR T cell immunotherapy for recurrent/refractory pediatric solid tumors.
Journal of Clinical Oncology·2024· 1 cited
First-in-human comparison of second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma
2024· 2 citedOpen Access
A Phase 2 Trial of SCRI-CAR19 Demonstrates Favorable Leukemia-Free Survival (LFS), with a Pilot Study of CD19-Expressing T-Cell Antigen Presenting Cells (CD19t T-APCs) Demonstrating Safety and Tolerability
Blood·2023Open Access
ENLIGHten-01: A phase 1 study of fluorescein-specific (FITC-E2)-CAR T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma.
Journal of Clinical Oncology·2023· 4 cited
Effect of bispecific B7H3 x CD19 CAR T cells on host CD19 expression and CAR T cell engraftment.
Journal of Clinical Oncology·2023· 2 cited
Abstract CT137: ENLIGHTen-01: a phase 1 study of fluorescein-specific (FITC-E2)-car T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma
Cancer Research·2023
Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023Open Access
Supplementary Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023Open Access
Supplementary Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023Open Access
Data from Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects
2023Open Access
Supplemental Figure 1 from Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
2023Open Access
supplemental legend from Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
2023Open Access
Supplemental Figure 2 from Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
2023Open Access
Data from Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
2023Open Access
Supplemental Figure 4 from Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
2023Open Access
Supplemental Figure 3 from Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Julie R. Park(39), Michael C. Jensen(38), Catherine Lindgren(22), Rebecca Gardner(22), Colleen Annesley(19), Olivia Finney(18), Ashley Wilson(17), Corinne Summers(16), Christopher Brown(16), Adam Johnson(16), Kristy Seidel(14), Annette Künkele(13), Agne Taraseviciute(12), Cindy A. Chang(12), Lisa S. Rolczynski(12), Stephanie Rawlings-Rhea(12), Kimberly Noonan(11), Ivan Borrello(11), Laura S. Finn(11), Carolina Berger(11)